Inflammation, glucocorticoids and risk of cardiovascular disease

被引：0
|
作者：
Frank Buttgereit
Gerd-Rüdiger Burmester
Brian J Lipworth
机构：
[1] Charité University Medicine,F Buttgereit is Professor of Rheumatology and G
[2] Berlin,R Burmester is Professor of Medicine in the Department of Rheumatology and Clinical Immunology
[3] Germany.,BJ Lipworth is Professor of Allergy and Respiratory Medicine and Head of the Asthma and Allergy Research Group in the Department of Clinical Pharmacology and Therapeutics
[4] University of Dundee School of Medicine,undefined
[5] Dundee,undefined
[6] Scotland,undefined
[7] UK.,undefined
来源：
Nature Clinical Practice Rheumatology | 2009年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A considerable increase in the risk of developing cardiovascular disease is conveyed not only by inflammation, but also by the use of glucocorticoids to treat inflammation. In this Viewpoint, the authors discuss the challenge of balancing the relative benefits and hazards of glucocorticoid treatment for inflammatory diseases, as well as the tantalizing prospect of identifying subgroups of the population at risk for cardiovascular disease.
引用
收藏
页码：18 / 19
页数：1
相关论文
共 50 条
  • [21] GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk
    Connelly, Margery A.
    Otvos, James D.
    Shalaurova, Irina
    Playford, Martin P.
    Mehta, Nehal N.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [22] Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
    Ridker, PM
    Cushman, M
    Stampfer, MJ
    Tracy, RP
    Hennekens, CH
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (14): : 973 - 979
  • [23] Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis
    Daniel J. DeMizio
    Laura B. Geraldino-Pardilla
    Rheumatology and Therapy, 2020, 7 : 19 - 33
  • [24] The Opioid Epidemic: Impact on Inflammation and Cardiovascular Disease Risk in HIV
    Corrilynn O. Hileman
    Grace A. McComsey
    Current HIV/AIDS Reports, 2019, 16 : 381 - 388
  • [25] GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk
    Margery A. Connelly
    James D. Otvos
    Irina Shalaurova
    Martin P. Playford
    Nehal N. Mehta
    Journal of Translational Medicine, 15
  • [26] The Opioid Epidemic: Impact on Inflammation and Cardiovascular Disease Risk in HIV
    Hileman, Corrilynn O.
    McComsey, Grace A.
    CURRENT HIV/AIDS REPORTS, 2019, 16 (05) : 381 - 388
  • [27] Association between inflammation and malnutrition as risk factors of cardiovascular disease
    Kaysen, GA
    BLOOD PURIFICATION, 2006, 24 (01) : 51 - 55
  • [28] Inflammation in Parkinson's disease: role of glucocorticoids
    Herrero, Maria-Trinidad
    Estrada, Cristina
    Maatouk, Layal
    Vyas, Sheela
    FRONTIERS IN NEUROANATOMY, 2015, 9
  • [29] Inflammation in Cardiovascular Disease
    Park, Chul Soo
    KOREAN CIRCULATION JOURNAL, 2017, 47 (03) : 314 - 315
  • [30] Inflammation and cardiovascular disease
    Willerson, JT
    FRONTIERS IN CARDIOVASCULAR HEALTH, 2003, 9 : 3 - 18
12345